Express Pharma

SCHOTT begins delivery of vials to package two billion doses of COVID-19 vaccines

SCHOTT’s 50-50 joint venture, SCHOTT KAISHA is supplying vials for COVID-19 vaccines to Serum Institute (India) and several other players in India

0 11,465

SCHOTT AG is supplying vials for up to two billion vaccination doses. The pharma glass and packaging company has reached agreements with global pharma companies, including key players in India. The global agreements became effective last month and first vials are already being delivered to companies in Asia, North America and Europe.

In India, SCHOTT’s 50-50 joint venture, SCHOTT KAISHA is supplying vials for COVID-19 vaccines to Serum Institute (India) and several other players. The joint venture operates four manufacturing facilities in the country located in Jambusar and Umarsadi in Gujarat, Daman, and Baddi in Himachal Pradesh. In addition, the company produces the pharma glass tubing for the packaging itself at its global sites including one in Jambusar in Gujarat.

The specialty glass company is ideally positioned to meet the challenging demand situation since it had started an investment program into its pharma business of $1 billion in 2019 already. In India, this includes a three-digit million-euro number for new Borosilicate glass melting tanks, and for its packaging operations an entirely new production site as well as new modules and lines.

All of SCHOTT’s 20 production sites for